Related Experiment Video
Updated: Jul 13, 2026

10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Re-building distribution networks to assure future microbicide access.
1Global Campaign for Microbicides, Washington, DC, USA. asforbes@path.org
Summary
Topical microbicides for HIV prevention are nearing availability. However, U.S. policies hinder the integration of family planning and HIV programs, weakening distribution networks essential for microbicide access.
Area of Science:
- Public Health
- Infectious Disease Prevention
- Women's Health
Background:
- Topical microbicides, designed to reduce women's HIV infection risk, are in late-stage efficacy testing.
- Successful microbicide deployment could significantly impact global public health, particularly in high-prevalence regions.
- International organizations support integrating family planning and HIV/AIDS programs to optimize resource allocation and service delivery.
Purpose of the Study:
- To analyze the impact of current U.S. policies on the integration of family planning and HIV/AIDS programs.
- To identify how policy restrictions impede the development of robust distribution networks for new HIV prevention technologies like microbicides.
- To inform strategies for overcoming policy barriers to ensure timely access to microbicides.
Main Methods:
- Policy analysis of U.S. funding restrictions and integration guidelines.
- Review of international public health and development strategies for HIV/AIDS and family planning.
- Assessment of existing distribution network capacities and potential for microbicide roll-out.
Main Results:
- U.S. policies, including funding restrictions and reluctance to integrate services, create significant impediments to family planning and HIV program integration.
- These policy barriers weaken, rather than strengthen, the distribution networks crucial for the effective roll-out of topical microbicides.
- The current policy landscape poses a risk to the successful and equitable access of women to this new HIV prevention technology.
Conclusions:
- Policy reform is urgently needed to facilitate the integration of family planning and HIV/AIDS services.
- Strengthening distribution networks through policy changes is essential for the successful public health deployment of microbicides.
- Addressing U.S. policy restrictions is critical to maximizing the impact of microbicides in women's HIV prevention efforts.
Related Concept Videos
Chemical Agents for Microbial Control
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

